Condition
Refractory Mixed Phenotype Acute Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Refractory Mixed Phenotype Acute Leukemia clinical trials that are recruiting, in United States. By phase: Phase 1/2 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Refractory Mixed Phenotype Acute Leukemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Decitabine plus FLAG‑Ida chemotherapy and total‑body irradiation before donor stem cell transplant for adults with high‑risk myeloid cancers | Phase 1/2 | Seattle, Washington | Recruiting | Apr 15, 2025 |
| Chemotherapy and Stem Cell Transplant for Relapsed or Refractory Blood Cancers | Phase 1 | Seattle, Washington | Recruiting | May 5, 2020 |
| Using a radioactive antibody followed by stem cell transplant to treat high-risk leukemia or myelodysplastic syndrome | Phase 1/2 | Seattle, Washington | Recruiting | Sep 14, 2018 |
| Using radioactive treatment before stem cell transplant for high-risk leukemia patients | Phase 1/2 | Seattle, Washington | Recruiting | Apr 25, 2017 |
All recruiting trials (4)
-
Decitabine plus FLAG‑Ida chemotherapy and total‑body irradiation before donor stem cell transplant for adults with high‑risk myeloid cancers
This test tries whether adding decitabine to FLAG‑Ida chemotherapy and total‑body irradiation before a donor stem cell transplant helps adults with high‑risk or relapsed myeloid blood cancers live longer and stay in remission.
-
Chemotherapy and Stem Cell Transplant for Relapsed or Refractory Blood Cancers
This study is testing a combination of two chemotherapy treatments and total body radiation to see if it helps people with relapsed or hard-to-treat blood cancers get ready for a stem cell transplant.
-
Using a radioactive antibody followed by stem cell transplant to treat high-risk leukemia or myelodysplastic syndrome
This study is testing a new radioactive treatment combined with a stem cell transplant to see if it can help people with high-risk leukemia or myelodysplastic syndrome feel better and improve their chances of recovery.
-
Using radioactive treatment before stem cell transplant for high-risk leukemia patients
This study is testing a new radioactive treatment given before a stem cell transplant to see if it can help high-risk leukemia patients by targeting cancer cells while protecting healthy ones.
Related topics
Quick answers
How many Refractory Mixed Phenotype Acute Leukemia clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.